MDT Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.…
Industry Peers
Medical DevicesKey Statistics
About Medtronic (NYSE: MDT)
›
Medtronic (NYSE: MDT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 95,000 employees.
The shares were at 99.94 USD on 20 November 2026, up 2.1% over 52 weeks. Its 52-week range is 73.31 USD to 106.33 USD: the price is 6.0% below the high and 36.3% above the low.
At a market capitalisation of 127.84B USD, it trades at 24.6 times trailing earnings and 15.6 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.5, so MDT is valued in line with them. It pays a dividend yielding 2.86% (it pays out 70% of its earnings), against a median of 2.28% among the dividend payers in that peer group.
Medtronic reports return on equity of 9.7%, an operating margin of 20.1% and revenue up 13.7% year over year.
Its debt exceeds its cash by 19.33B USD, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 26 analysts cover the stock, with an average rating of Buy; their mean price target of 106.96 USD is 7.0% above the current price.